Implementation and Outcomes of a Mobile Extracorporeal Membrane Oxygenation Program in the United States During the Coronavirus Disease 2019 Pandemic

Autor: Travis Pollema, Bradley Genovese, Cassia Yi, Scott Chicotka, Eugene Golts, Robert L. Owens, Mazen Odish, Michael M. Madani
Rok vydání: 2021
Předmět:
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
medicine.medical_treatment
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
coronavirus
Patient characteristics
Transportation
030204 cardiovascular system & hematology
Cardiorespiratory Medicine and Haematology
Credentialing
Article
mobile ECMO
Limited access
03 medical and health sciences
coronavirus disease 2019
0302 clinical medicine
Extracorporeal Membrane Oxygenation
030202 anesthesiology
Anesthesiology
Pandemic
Extracorporeal membrane oxygenation
Hospital discharge
Medicine
Humans
Pandemics
transportation
business.industry
SARS-CoV-2
Prevention
COVID-19
extracorporeal membrane oxygenation
United States
Coronavirus
surgical procedures
operative
Anesthesiology and Pain Medicine
Good Health and Well Being
Mobile ECMO
Emergency medicine
Cardiology and Cardiovascular Medicine
business
severe acute respiratory syndrome coronavirus 2
Zdroj: Journal of cardiothoracic and vascular anesthesia, vol 35, iss 10
Journal of Cardiothoracic and Vascular Anesthesia
ISSN: 1532-8422
Popis: The coronavirus disease 2019 (COVID-19) pandemic began in the United States around March 2020. Because of limited access to extracorporeal membrane oxygenation (ECMO) in the authors' region, a mobile ECMO team was implemented by April 2020 to serve patients with COVID-19. Several logistical and operational needs were assessed and addressed to ensure a successful program, including credentialing, equipment management, and transportation. A multidisciplinary team was included in the planning, decision-making, and implementation of the mobile ECMO. From April 2020 to January 2021, mobile ECMO was provided to 22 patients in 13 facilities across four southern California counties. The survival to hospital discharge of patients with COVID-19 who received mobile ECMO was 52.4% (11 of 21) compared with 45.2% (14 of 31) for similar patients cannulated in-house. No significant patient or transportation complications occurred during mobile ECMO. Neither the ECMO nor transport teams experianced unprotected exposures to or infections with severe acute respiratory syndrome coronavirus 2. Herein, the implementation of the mobile ECMO team is reviewed, and patient characteristics and outcomes are described.
Databáze: OpenAIRE
Externí odkaz: